Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Bradley W Blaser, MD, PhD, Haesook Kim, PhD, Jorge Plutzky, MD, Edwin Alyea, III, MD, Vincent Ho, MD, Corey Cutler, MD, MPH, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Joseph H. Antin, MD, Robert Soiffer, MD

Blood (2010) 116 (21): 3457.

https://doi.org/10.1182/blood.V116.21.3457.3457

Published: 2010

Journal Articles

Decreased Telomerase Activity In CD4 Regulatory T Cells Is Associated with Severity of Chronic Graft-Versus-Host Disease (cGVHD) After Hematopoietic Stem Cell Transplantation (HSCT)

Yutaka Kawano, MD, PhD, Haesook Kim, PhD, Ken-ichi Matsuoka, MD, PhD, Suzan Lazo-Kallanian, John Daley, Joseph H. Antin, MD, Robert Soiffer, MD, Jerome Ritz, MD

Blood (2010) 116 (21): 1257.

https://doi.org/10.1182/blood.V116.21.1257.1257

Published: 2010

Journal Articles

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Philippe Armand, MD, PhD, Waleska Perez, MPH, Mei-Jie Zhang, PhD, Haesook Kim, PhD, Thomas R. Klumpp, MD, Paola Dal Cin, PhD, Edmund K Waller, MD, PhD, Mark R. Litzow, MD, Jane L. Liesveld, MD, Hillard M. Lazarus, MD, FACP, Andrew Artz, MD, MS, Vikas Gupta, MD, MRCP, FRCPath, Bipin N. Savani, MD, Philip L. McCarthy, MD, Jean-Yves Cahn, MD, Harry Schouten, Jurgen Finke, MD, Edward D. Ball, MD, Mahmoud Aljurf, MD, Corey Cutler, MD, MPH, FRCPC, Jacob M. Rowe, Joseph H. Antin, MD, Luis M Isola, MD, Paolo Di Bartolomeo, MD, Bruce Camitta, MD, Alan M Miller, MD, PhD, Mitchell S. Cairo, MD, Keith E. Stockerl-Goldstein, MD, Jorge Sierra, MD, Mary Lynn Savoie, MD, FRCPC, Joerg Halter, MD, Patrick J Stiff, MD, Chadi Nabhan, MD, FACP, Ann A. Jakubowski, MD, PhD, Donald Bunjes, MD, Effie W. Petersdorf, MD, Steven M Devine, MD, Richard Maziarz, MD, Martin Bornhauser, MD, Victor A Lewis, MD, David I. Marks, MBBS, PHD, Christopher N Bredeson, MD, MSc, FRCPC, Robert Soiffer, MD, Daniel J. Weisdorf, MD

Blood (2010) 116 (21): 680.

https://doi.org/10.1182/blood.V116.21.680.680

Published: 2010

Journal Articles

Effects of Daily Low Dose IL-2 Therapy on Homeostatic Regulation of CD4+Foxp3+ Regulatory T Cells In Patients with Chronic Graft-Versus-Host Disease

Ken-ichi Matsuoka, MD, PhD, John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, O. Gregory Bascug, Sean McDonough, MS, Joseph H. Antin, MD, Robert Soiffer, MD, Jerome Ritz, MD

Blood (2010) 116 (21): 895.

https://doi.org/10.1182/blood.V116.21.895.895

Published: 2010

Journal Articles

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

Corey Cutler, MD, MPH, FRCPC, Rachel Mitrovich, Grace Kao, MD, Vincent Ho, MD, Edwin Alyea, MD, John Koreth, MBBS, Philippe Armand, MD, Bimalangshu Dey, MD, Thomas Spitzer, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Karen Ballen, MD

Blood (2007) 110 (11): 2016.

https://doi.org/10.1182/blood.V110.11.2016.2016

Published: 2007

Journal Articles

Immunoproteomic Identification of Graft-Versus-Leukemia Targets in Patients with Chronic Lymphocytic Leukemia.

Ovidiu Marina, MS, Melinda Biernacki, Ann Cai, Wandi Zhang, Jonathan S. Duke-Cohan, PhD, Vladimir Brusic, PhD, Fenglong Liu, PhD, Edwin Alyea, MD, Christine M. Canning, Robert Soiffer, MD, Jerome Ritz, MD, Catherine J. Wu, MD

Blood (2007) 110 (11): 71.

https://doi.org/10.1182/blood.V110.11.71.71

Published: 2007

Journal Articles

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Julia Brown, PhD, Karen Ballen, MD, Sean McDonough, Xupeng Ge, MD, PhD, Kristen Stevenson, PhD, Haesook Kim, PhD, Carol Reynolds, Bimalangshu R. Dey, MD, PhD, Steve McAfee, MD, Eyal Attar, MD, Thomas Spitzer, MD, Corey Cutler, MD, Vincent Ho, MD, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 1057.

https://doi.org/10.1182/blood.V110.11.1057.1057

Published: 2007

Journal Articles

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Karen K. Ballen, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, McAfee Steve, MD, Bimalanghsu R. Dey, MD, Eyal Attar, MD, Edwin Alyea, MD, Corey Cutler, MD, Vincent Ho, MD, Stephanie Lee, MD, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2005) 106 (11): 2048.

https://doi.org/10.1182/blood.V106.11.2048.2048

Published: 2005

Journal Articles

Sirolimus and Tacrolimus as Graft-vs.-Host Disease Prophylaxis in Allogeneic Stem Cell Transplantation: The Dana-Farber Cancer Institute Experience.

Corey Cutler, MD MPH FRCPC, Shuli Li, MS, Haesook T. Kim, PhD, Edwin Alyea, MD, Vincent Ho, MD, Stephanie J. Lee, MD MPH, David C. Fisher, MD, Robert Schlossman, MD, David Miklos, MD PhD, Stephen Sonis, DMD DMSc, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2004) 104 (11): 1227.

https://doi.org/10.1182/blood.V104.11.1227.1227

Published: 2004

Journal Articles

Sirolimus and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation.

N. Lynn Henry, MD, Shuli Li, MS, Haesook T. Kim, PhD, Colm Magee, MD MPH, Edwin Alyea, MD, Vincent Ho, MD, Stephanie J. Lee, MD MPH, Robert Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD MPH FRCPC

Blood (2004) 104 (11): 1834.

https://doi.org/10.1182/blood.V104.11.1834.1834

Published: 2004

Journal Articles

Prevention of Acute GVHD with Sirolimus Does Not Abrogate the Risk of Chronic GVHD.

Corey Cutler, MD, MPH, FRCPC, Shuli Li, MS, Haesook T. Kim, PhD, Edwin Alyea, MD, Vincent Ho, MD, Stephanie J. Lee, MD, MPH, David C. Fisher, MD, Robert Schlossman, MD, David Miklos, MD, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2004) 104 (11): 3317.

https://doi.org/10.1182/blood.V104.11.3317.3317

Published: 2004

Journal Articles

Oral Mucositis Incidence and Severity after Methotrexate and Non-Methotrexate Containing GVHD Prophylaxis Regimens.

Corey Cutler, MD MPH FRCPC, Shuli Li, MS, Haesook T. Kim, PhD, Patricia Laglenne, MS RD, Colleen Ford, Vincent Ho, MD, Stephanie J. Lee, MD MPH, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Stephen Sonis, DMD DMSc

Blood (2004) 104 (11): 351.

https://doi.org/10.1182/blood.V104.11.351.351

Published: 2004

Journal Articles

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Corey Cutler, MD MPH FRCPC, David Miklos, MD PhD, Stephanie J. Lee, MD MPH, Sook-Bin Woo, DMD, Nathaniel Treister, DMD, Don Bienfang, MD, Lloyd Klickstein, MD PhD, Jesse Levin, BA, Katherine H. Miller, BA, Carol Reynolds, PhD, Mildred Pasek, RN, Vincent Ho, MD, Jerome Ritz, MD PhD, Joseph H. Antin, MD, Robert Soiffer, MD, Edwin Alyea, MD

Blood (2004) 104 (11): 2251.

https://doi.org/10.1182/blood.V104.11.2251.2251

Published: 2004

NARROW

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Decreased Telomerase Activity In CD4 Regulatory T Cells Is Associated with Severity of Chronic Graft-Versus-Host Disease (cGVHD) After Hematopoietic Stem Cell Transplantation (HSCT)

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Effects of Daily Low Dose IL-2 Therapy on Homeostatic Regulation of CD4+Foxp3+ Regulatory T Cells In Patients with Chronic Graft-Versus-Host Disease

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

Immunoproteomic Identification of Graft-Versus-Leukemia Targets in Patients with Chronic Lymphocytic Leukemia.

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Sirolimus and Tacrolimus as Graft-vs.-Host Disease Prophylaxis in Allogeneic Stem Cell Transplantation: The Dana-Farber Cancer Institute Experience.

Sirolimus and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation.

Prevention of Acute GVHD with Sirolimus Does Not Abrogate the Risk of Chronic GVHD.

Oral Mucositis Incidence and Severity after Methotrexate and Non-Methotrexate Containing GVHD Prophylaxis Regimens.

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only